Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature
British Journal of Dermatology2017Vol. 177(5), pp. 1202–1207
Citations Over TimeTop 11% of 2017 papers
Stefan E. Lowenstein, Giorgia L. Garrett, Amanda E. Toland, Anokhi Jambusaria‐Pahlajani, Maryam M. Asgari, Adèle C. Green, Eric A. Engels, Sarah T. Arron
Abstract
Long-term iatrogenic immunosuppression increases the risk of cutaneous malignancies in organ transplant recipients (OTRs), particularly the keratinocyte cancers basal cell carcinoma and cutaneous squamous cell carcinoma (cSCC). cSCC is the most common malignancy in OTRs, with the risk increased to over 65-fold in transplanted patients relative to the general population. There have been very few risk prediction tools developed for accurate determination of the risk of developing keratinocyte cancers in the OTR population. This review summarizes the prediction tools developed to date, and outlines future directions for developing more accurate prediction models that are clinically useful for the transplant physician and dermatologist.
Related Papers
- → Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population(2005)150 cited
- → Ultraviolet Carcinogenesis in Nonmelanoma Skin Cancer Part II: Review and Update on Epidemiologic Correlations(2004)44 cited
- → Skin Cancer (Basal Cell Carcinoma, Squamous Cell Carcinoma, and Malignant Melanoma): New Cases, Treatment Practice, and Health Care Costs in New Brunswick, Canada, 2002–2010(2014)11 cited
- → Epidemiology of Skin Cancer(2023)3 cited
- → The geographical variation of melanoma, basal and squamous cell carcinoma in England(2023)1 cited